FOLH1 and neoplasm: Another study in mice with intramuscular LNCaP xenografts used 213Bi conjugated to a J591 anti-PSMA monoclonal antibody, which resulted in improved tumor-free survival, effectively stopped the growth of LNCaP spheroids, and reduced prostate-specific antigen levels [97].